Fine-tuning Management and Perioperative Immunotherapy for Optimized Outcomes in cSCC - CME

CME

Title: Fine-tuning Management and Perioperative Immunotherapy for Optimized Outcomes in cSCC

Description: Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer, with basal cell carcinoma (BCC) being the only skin cancer more common. While surgical excision of the primary site can cure the majority of cSCC cases, an aggressive subset of cSCC will persist with clinicopathological features associated with higher risk of recurrence, metastasis, and mortality. Clinicians must be aware of this crucial aspect of cSCC care as well as other complex cSCC cases. An expert panel of one dermatologist and one cutaneous oncologist will discuss how to assess patients who may benefit from ICIs and how to monitor and manage immune-related adverse events. The panel will also discuss integrating neoadjuvant ICIs for eligible patients with resectable cSCC and how to manage treatment-related adverse events, including those associated with ICIs.

Target Audience: The primary target audience for this activity are dermatologic-oncologists, dermatologists, and other HCPs caring for patients with non-melanoma skin cancers.

Learning Objectives

Develop multidisciplinary strategies to optimize treatment pathways for patients with cSCC from risk assessment through treatment
Evaluate practice-changing data supporting the use of perioperative ICIs for patients with resectable cSCC
Apply multidisciplinary approaches to the monitoring and management of treatment-related adverse events

Keywords: skin cancer, non-melanoma skin cancers, cutaneous squamous cell carcinoma (CSCC)

Disclosures and Disclaimers: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accredited Providers

Commercial Support

Credit Information

Credit Type	Units / Unit Type	Board
AMA PRA Category 1 Credit	1 Credits	ACCME- Accreditation Council for Continuing Medical Education